Literature DB >> 25422708

Cephalometric Features of Moyamoya Disease: A case control study.

Adnan I Qureshi1, Waqas I Gilani1, Sarwat I Gilani1, Malik M Adil1.   

Abstract

CONTRIBUTION OF AUTHORS: Adnan I Qureshi, Waqas I Gilani MD, Sarwat I. Gilani MD, Malik M. Adil MD . Equally assisted in the synthesis and discussion of ideas, and share equal responsibility for the information written in the manuscript above. CONFLICT OF INTEREST: No conflict of interests. RUNNING TITLE: Cephalometric Features of Moyamoya Disease.
BACKGROUND: Moyamoya disease is highly prevalent among patients with syndromes that have unique cephalometric characteristics such as Down syndrome. We performed a case control study to investigate the relationship between cephalometric parameters and Moyamoya disease.
METHODS: Patients [aged 16-82 years] with angiographically confirmed Moyamoya disease who underwent cranial CT scan were analyzed. We identified three controls for each patient who were matched for age (±1 year), gender, and race (white or African American). The fronto-occipital diameter, bi-parietal diameter, and distance between bregma and occiput were measured from the head CT scans of cases and controls. The cephalic index was calculated by determining the ratio between bi-parietal diameter and fronto-occipital diameter and multiplying the value by 100.
RESULTS: A total of 13 cases of Moyamoya disease and 39 controls were analyzed. The stage of Moyamoya disease in cases was as follows: stage 1 (n=0), stage 2 (n=1), stage 3 (n=4), stage 4 (n=2), stage 5 (n=5) and stage 6 (n=1). There was a significantly greater bi-parietal diameter in Moyamoya disease patients compared with controls (141.5±3.7 mm versus 136.9±5.4 mm, p=0.007). There was a significantly greater fronto-occipital diameter in Moyamoya disease patients compared with controls (186.5±6.5 mm versus 180.2±8.7mm, p=0.02). The distance between bregma and occiput was shorter among cases compared with controls (81.1±6.2 versus 87.5±7.0, p=0.01).
CONCLUSIONS: We observed an association between cephalometric parameters and Moyamoya disease. Further study of the unique cephalometric characteristics among Moyamoya disease patients may provide additional insight into disease occurrence in white and African American populations.

Entities:  

Keywords:  Moyamoya disease; cephalic index; cephalometry; fronto-occipital diameter; race/ethnicity

Year:  2014        PMID: 25422708      PMCID: PMC4241409     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  35 in total

1.  Preoperative and postoperative transcranial Doppler sonographic evaluations of the cerebral hemodynamics of craniostenosis.

Authors:  Bingyu Wang; Zhihua Cheng; Xiongzheng Mu; Baohua Fan; Zhilin Guo
Journal:  J Craniofac Surg       Date:  2010-03       Impact factor: 1.046

2.  Moyamoya disease in adults: the role of cerebral revascularization.

Authors:  Gregory J Zipfel; Douglas J Fox; Dennis J Rivet
Journal:  Skull Base       Date:  2005-02

3.  Immunohistochemical reactions for fibroblast growth factor receptor in arteries of patients with moyamoya disease.

Authors:  H Suzui; M Hoshimaru; J A Takahashi; H Kikuchi; M Fukumoto; M Ohta; N Itoh; M Hatanaka
Journal:  Neurosurgery       Date:  1994-07       Impact factor: 4.654

4.  Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease.

Authors:  Daraspreet S Kainth; Saqib A Chaudhry; Hunar S Kainth; Fareed K Suri; Adnan I Qureshi
Journal:  Neurosurgery       Date:  2013-02       Impact factor: 4.654

5.  Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency.

Authors:  J A Greenwald; B J Mehrara; J A Spector; S M Warren; F E Crisera; P J Fagenholz; P J Bouletreau; M T Longaker
Journal:  J Bone Miner Res       Date:  2000-12       Impact factor: 6.741

6.  TGF-beta1, FGF-2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures.

Authors:  Arun K Gosain; René F Recinos; Michael Agresti; Ashwani K Khanna
Journal:  Plast Reconstr Surg       Date:  2004-05       Impact factor: 4.730

7.  Microarray analysis of the role of regional dura mater in cranial suture fate.

Authors:  Matthew D Kwan; Derrick C Wan; Zhen Wang; Deepak M Gupta; Bethany J Slater; Michael T Longaker
Journal:  Plast Reconstr Surg       Date:  2008-08       Impact factor: 4.730

8.  Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease.

Authors:  M Hojo; M Hoshimaru; S Miyamoto; W Taki; I Nagata; M Asahi; N Matsuura; R Ishizaki; H Kikuchi; N Hashimoto
Journal:  J Neurosurg       Date:  1998-10       Impact factor: 5.115

Review 9.  Moyamoya disease: a summary.

Authors:  Gordon M Burke; Allan M Burke; Arun K Sherma; Michael C Hurley; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

10.  Neuroradiologic manifestations of Loeys-Dietz syndrome type 1.

Authors:  V J Rodrigues; S Elsayed; B L Loeys; H C Dietz; D M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2009-06-25       Impact factor: 3.825

View more
  1 in total

1.  Distinctive facial features in idiopathic Moyamoya disease in Caucasians: a first systematic analysis.

Authors:  Markus Kraemer; Quoc Bao Huynh; Dagmar Wieczorek; Brunilda Balliu; Barbara Mikat; Stefan Boehringer
Journal:  PeerJ       Date:  2018-06-27       Impact factor: 2.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.